The Alpha1-Liver Team from Aachen, Germany, which coordinates the European study group for alpha1-antitrypsin deficiency-related liver disease, has published the latest results on liver involvement in mild alpha1-antitrypsin deficiency in the renowned journal, Gastroenterology. This work appears a year after the contribution that focused on the liver phenotype in severe alpha1-antitrypsin deficiency and was also published in Gastroenterology. [read more]

The results of the study ‘High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation’ by Pape et al. were accepted in Liver International, and posted online ahead of print. [read more]

The results of the study ‘Efficacy and safety of selective decontamination of the digestive tract (SDD) to prevent recurrent hepatic cyst infections in polycystic liver disease: a retrospective case series’ by Bernts et al. were accepted in Antimicrob Chemother, and posted online ahead of print.The study is a collaborative effort of two ERN RARE-LIVER centers with special interest in ADPKD/ADPLD.  [read more]

The Aachen Alpha1-team, led by Priv.-Doz. Dr. Pavel Strnad and Dr. Karim Hamesch, who are responsible for the European Reference [read more]

The results of the study ‘Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 Months’ by Pape et al. were accepted in Clinical Gastroenterology and Hepatology, and posted online ahead of print.  [read more]

In March 2020, Harpavat et. al published their study “Diagnostic Yield of Newborn Screening for Biliary Atresia Using Direct or Conjugated Bilirubin Measurements” in the Journal of the American Medical Association (DOI: 10.1001/jama.2020.0837).  [read more]